Effect and cost of two successive home visits to increase HIV testing coverage: a prospective study in Lesotho, Southern Africa

by Niklaus Daniel Labhardt, Isaac Ringera, Thabo Ishmael Lejone, Alain Amstutz, Thomas Klimkait, Josephine Muhairwe, Tracy Renee Glass
Published 2019-11-01

27 Therapeutic immune recovery prevents emergence of CXCR4-tropic HIV-1

by J. Bader, M. Daeumer, A. Thielen, F. Schoni-Affolter, J. Boeni, M. Gorgievski-Hrisoho, G. Martinetti, T. Klimkait
Published 2016-07-01

Additive manufacturing of pure tungsten by means of selective laser beam melting with substrate preheating temperatures up to 1000 ∘C

by A. v. Müller, G. Schlick, R. Neu, C. Anstätt, T. Klimkait, J. Lee, B. Pascher, M. Schmitt, C. Seidel
Published 2019-05-01

Preserved antigen-specific immune response in patients with multiple sclerosis responding to IFNβ-therapy.

by Matthias Mehling, Stefanie Fritz, Patricia Hafner, Dominik Eichin, Tomomi Yonekawa, Thomas Klimkait, Raija L P Lindberg, Ludwig Kappos, Christoph Hess
Published 2013-01-01

Alcohol use and depression: link with adherence and viral suppression in adult patients on antiretroviral therapy in rural Lesotho, Southern Africa: a cross-sectional study

by Bernard Cerutti, Barbara Broers, Motlomelo Masetsibi, Olatunbosun Faturiyele, Likabelo Toti-Mokoteli, Mokete Motlatsi, Joelle Bader, Thomas Klimkait, Niklaus D Labhardt
Published 2016-09-01

The viral load monitoring cascade in a resource-limited setting: A prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho.

by Tracy Renee Glass, Lipontso Motaboli, Bienvenu Nsakala, Malebanye Lerotholi, Fiona Vanobberghen, Alain Amstutz, Thabo Ishmael Lejone, Josephine Muhairwe, Thomas Klimkait, Niklaus Daniel Labhardt
Published 2019-01-01

Inferring epidemic contact structure from phylogenetic trees.

by Gabriel E Leventhal, Roger Kouyos, Tanja Stadler, Viktor von Wyl, Sabine Yerly, Jürg Böni, Cristina Cellerai, Thomas Klimkait, Huldrych F Günthard, Sebastian Bonhoeffer
Published 2012-01-01

Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho.

by Alain Amstutz, Bienvenu Lengo Nsakala, Fiona Vanobberghen, Josephine Muhairwe, Tracy Renée Glass, Tilo Namane, Tlali Mpholo, Manuel Battegay, Thomas Klimkait, Niklaus Daniel Labhardt
Published 2020-09-01

High failure rates of protease inhibitor-based antiretroviral treatment in rural Tanzania - A prospective cohort study.

by Rahel E Bircher, Alex J Ntamatungiro, Tracy R Glass, Dorcas Mnzava, Amina Nyuri, Herry Mapesi, Daniel H Paris, Manuel Battegay, Thomas Klimkait, Maja Weisser, KIULARCO study group
Published 2020-01-01

Decreasing Proportion of Recent Infections among Newly Diagnosed HIV-1 Cases in Switzerland, 2008 to 2013 Based on Line-Immunoassay-Based Algorithms.

by Jörg Schüpbach, Christoph Niederhauser, Sabine Yerly, Stephan Regenass, Meri Gorgievski, Vincent Aubert, Diana Ciardo, Thomas Klimkait, Günter Dollenmaier, Corinne Andreutti, Gladys Martinetti, Marcel Brandenberger, Martin D Gebhardt
Published 2015-01-01

Parent-offspring regression to estimate the heritability of an HIV-1 trait in a realistic setup

by Nadine Bachmann, Teja Turk, Claus Kadelka, Alex Marzel, Mohaned Shilaih, Jürg Böni, Vincent Aubert, Thomas Klimkait, Gabriel E. Leventhal, Huldrych F. Günthard, Roger Kouyos, the Swiss HIV Cohort Study
Published 2017-05-01

SESOTHO trial (“Switch Either near Suppression Or THOusand”) – switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia bel...

by Alain Amstutz, Bienvenu Lengo Nsakala, Fiona Vanobberghen, Josephine Muhairwe, Tracy Renée Glass, Beatrice Achieng, Mamorena Sepeka, Katleho Tlali, Lebohang Sao, Kyaw Thin, Thomas Klimkait, Manuel Battegay, Niklaus Daniel Labhardt
Published 2018-02-01

Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens.

by Alexandra U. Scherrer, Jürg Böni, Sabine Yerly, Thomas Klimkait, Vincent Aubert, Hansjakob Furrer, Alexandra Calmy, Matthias Cavassini, Luigia Elzi, Pietro L. Vernazza, Enos Bernasconi, Bruno Ledergerber, Huldrych F. Günthard
Published 2013-01-01

Same day ART initiation versus clinic-based pre-ART assessment and counselling for individuals newly tested HIV-positive during community-based HIV testing in rural Lesotho – a ran...

by Niklaus Daniel Labhardt, Isaac Ringera, Thabo Ishmael Lejone, Phofu Masethothi, T’sepang Thaanyane, Mashaete Kamele, Ravi Shankar Gupta, Kyaw Thin, Bernard Cerutti, Thomas Klimkait, Christiane Fritz, Tracy Renée Glass
Published 2016-04-01

High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease

by Yerly Sabine, Shah Cyril, Martinetti Gladys, Andreutti Corinne, Steffen Ingrid, Gorgievski Meri, Bürgisser Philippe, Regenass Stephan, Bisset Leslie R, Schüpbach Jörg, Klimkait Thomas, Gebhardt Martin, Schöni-Affolter Franziska, Rickenbach Martin
Published 2011-09-01

Safety and tolerance of lymph node biopsies from chronic HIV-1 volunteers in rural Tanzania

by Catherine Gerald Mkindi, Elias Antony Marandu, Ngisi Masawa, Farida Bani, Amina Nyuri, Theonestina Byakuzana, Thomas Klimkait, Song Ding, Giuseppe Pantaleo, Manuel Battegay, Nina Orlova-Fink, Maja Weisser-Rohacek, Claudia Daubenberger
Published 2019-09-01

Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics.

by Denise Kühnert, Roger Kouyos, George Shirreff, Jūlija Pečerska, Alexandra U Scherrer, Jürg Böni, Sabine Yerly, Thomas Klimkait, Vincent Aubert, Huldrych F Günthard, Tanja Stadler, Sebastian Bonhoeffer, Swiss HIV Cohort Study
Published 2018-02-01

VIBRA trial – Effect of village-based refill of ART following home-based same-day ART initiation vs clinic-based ART refill on viral suppression among individuals living with HIV:...

by Alain Amstutz, Thabo Ishmael Lejone, Lefu Khesa, Josephine Muhairwe, Bienvenu Lengo Nsakala, Katleho Tlali, Moniek Bresser, Fabrizio Tediosi, Mathebe Kopo, Mpho Kao, Thomas Klimkait, Manuel Battegay, Tracy Renée Glass, Niklaus Daniel Labhardt
Published 2019-08-01

The HOSENG trial – Effect of the provision of oral self-testing for absent and refusing individuals during a door-to-door HIV-testing campaign on testing coverage: protocol of a cl...

by Alain Amstutz, Thabo Ishmael Lejone, Lefu Khesa, Josephine Muhairwe, Bienvenu Lengo Nsakala, Katleho Tlali, Moniek Bresser, Fiona Vanobberghen, Mathebe Kopo, Mpho Kao, Thomas Klimkait, Manuel Battegay, Niklaus Daniel Labhardt, Tracy Renée Glass
Published 2019-08-01

Assessing predicted HIV-1 replicative capacity in a clinical setting.

by Roger D Kouyos, Viktor von Wyl, Trevor Hinkley, Christos J Petropoulos, Mojgan Haddad, Jeannette M Whitcomb, Jürg Böni, Sabine Yerly, Cristina Cellerai, Thomas Klimkait, Huldrych F Günthard, Sebastian Bonhoeffer, Swiss HIV Cohort Study
Published 2011-11-01